Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth.
Billy Candra Scientists at the Icahn School of Medicine at Mount Sinai have unveiled a groundbreaking experimental...
women’s health
Scientists discover why cancer drugs don’t work for everyone
George Ongkojoyo The pursuit of precision medicine in oncology has long been hindered by a fundamental paradox:...
Nagoya University Researchers Uncover How Ovarian Cancer Cells Recruit Mesothelial Cells to Accelerate Metastasis and Resist Chemotherapy
Ovarian cancer has long held a reputation as the "silent killer" of gynecological oncology, characterized...
Breakthrough in Cancer Immunotherapy: Redesigned CD40 Antibody Shows Complete Remission in Early Clinical Trials
The field of oncology is witnessing a potential paradigm shift in immunotherapy following the publication...
New Research Reveals How Lysosomal Storage and Heterogeneous Drug Distribution Influence the Efficacy of PARP Inhibitors in Ovarian Cancer Patients
The fundamental challenge of modern oncology lies in the unpredictable nature of therapeutic response, where...
Comprehensive Meta-Analysis Finds No Link Between Prenatal Acetaminophen Exposure and Neurodevelopmental Risks in Children
A landmark study led by researchers at City St George’s, University of London, has concluded...
Unveiling the Intricate Architecture of Toxoplasma Cysts and the Functional Diversity of Bradyzoite Subtypes in Chronic Infection
In a landmark study that challenges decades of parasitological assumptions, researchers at the University of...
A smarter way to screen for breast cancer is emerging
The landscape of breast cancer screening is on the cusp of a transformative shift, moving...
Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth.
Researchers at the Icahn School of Medicine at Mount Sinai have unveiled a transformative approach...
Revolutionizing Colorectal Cancer Immunotherapy: Sloan Kettering Institute Uncovers Dual Nature of Treg Cells
In a significant paradigm shift for cancer immunotherapy, researchers at the Sloan Kettering Institute (SKI)...
